Answers are grounded in this paper and cite their sources.
Capecitabine is an anticancer agent and is the oral prodrug of 5-fluorouracil (5-FU). In this study an ultra-performance liquid chromatography coupled to turbo ion spray tandem mass spectrometry (UPLC-MS/MS) method was developed and validated to quantify capecitabine and its metabolites including 5’-deoxy-5-fluorocytidine (5’-dFCR), 5’-deoxy-5-fluorouridine (5’-dFUR), 5-FU, and fluoro-β-alanine (FBAL) in lithium heparinized human plasma. Analytes were extracted by protein precipitation, chromatographically separated by Acquity UPLC HSS T3 column with gradient elution and analyzed with a tandem mass spectrometer equipped with an electrospray ionization source. Capecitabine and 5’-dFCR were quantified in positive ion mode and 5’-dFUR, 5-FU and FBAL were quantified in negative ion mode. Total chromatographic run time was 9 min. Stable labeled isotopes were used as internal standard for all analytes. The assay was validated over the range from 25.0 to 2.500 ng/mL for capecitabine, 10.0 to 1.000 ng/mL for 5’-dFCR, 5’-dFUR, and 5-FU and 50 to 5.000 ng/mL for FBAL in human plasma. Validation results have shown the developed assay allows for a high throughput and reliable quantitative analysis of capecitabine, 5’-dFCR, 5’-dFUR, 5-FU and FBAL in plasma samples.
No takes yet. Share an insight, caveat, or question.
Knikman et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: